Pentanoic acid,2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethylester cas no:56124-62-0
Synonyms: Pentanoic acid,2-[1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethylester, (2S-cis)-;AD 32;Antibiotic AD 32;N-Trifluoroacetyladriamycin14-valerate;N-Trifluoroacetyldoxorubicin 14-valerate;NSC 246131;Trifluoroacetyladriamycin 14-valerate;Valstar;
NamePentanoic acid,2-[(2S,4S)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethylester
CAS56124-62-0
SynonymsPentanoic acid,2-[1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-[[2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-a-L-lyxo-hexopyranosyl]oxy]-2-naphthacenyl]-2-oxoethylester, (2S-cis)-;AD 32;Antibiotic AD 32;N-Trifluoroacetyladriamycin14-valerate;N-Trifluoroacetyldoxorubicin 14-valerate;NSC 246131;Trifluoroacetyladriamycin 14-valerate;Valstar;
Molecular FormulaC34H36F3NO13
Molecular Weight723.64
refractive index1.618
Hazard Xi
Risk R36/37/38
Safety
Poison by intraperitoneal route. Human mutation data reported. When heated to decomposition it emits toxic fumes of F− and NOx.Safety information of Valrubicin (CAS NO.56124-62-0):
Hazard Codes 
Xi
Risk Statements
36/37/38 Irritating to eyes, respiratory system and skin
Safety Statements
26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice
37/39 Wear suitable gloves and eye/face protection
| 1. |
|
dnd-hmn:lym 3 mg/L
|
|
CJBIAE Canadian Journal of Biochemistry. 58 (1980),720. |
| 2. |
|
oms-hmn:lym 1 mg/L
|
|
CNREA8 Cancer Research. 41 (1981),2745. |
| 3. |
|
ipr-mus LD50:109 mg/kg
|
|
NCISP* National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program, Bethesda, MD 20205 JAN86 . |
